Injective Protocol has filed a transfer agent registration with the U.S. Securities and Exchange Commission, signaling a formal step toward bringing regulated real-world assets onto its blockchain. The submission, confirmed through regulatory filings, positions the layer-1 network to act as a compliant intermediary for tokenized securities and other regulated instruments.

According to the wire report, the registration would allow Injective to maintain shareholder records, process transfers, and handle dividend distributions for tokenized assets issued on its platform. This infrastructure layer is seen as critical for bridging traditional finance with decentralized markets while adhering to existing securities laws.

The move aligns with a broader industry trend where blockchain protocols seek regulated pathways for real-world asset tokenization. By securing transfer agent status, Injective aims to offer issuers a compliant framework for on-chain representation of equities, bonds, and fund shares without relying on third-party custodians.

Market observers note that SEC approval is not guaranteed and the review timeline remains uncertain. The commission has previously scrutinized digital asset platforms for compliance gaps, and any registration would come with ongoing reporting and operational obligations.

Injective's native token, INJ, showed modest reaction following the disclosure. The protocol has previously emphasized its focus on institutional-grade infrastructure, and the transfer agent filing represents a tangible milestone in that roadmap.